IPO registrations (S-1, F-1) · Registrants
Med BioGene Inc.
- SEC CIK
- 1478455 · filings on EDGAR ↗
- Registration
- Form F-1, first filed 2009-12-28, last 2010-06-22; 1 initial registration, 8 amendments
- Outcome
- Withdrawal requested 2012-02-02
- Industry (SIC)
- Services-Medical Laboratories 8071
- Incorporated in
- A1
- Business address
- #300 - 2386 EAST MALL, GERALD MCGAVIN BUILDING, Vancouver, A1 V6T 1Z3
- EDGAR entity type
- other
Offering terms
- Proposed price range
- $8.00–$10.00 per share (F-1/A filed 2010-06-09)
- Shares offered
- 2,777,778
- Listing
- Nasdaq under the symbol MBGI
- Lead underwriters
- Rodman & Renshaw
- Syndicate
- ThinkEquity; Dundee Securities Inc
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
Filings 10
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2009-12-28 | F-1 | F-1 (foreign registration) | Med BioGene Inc. | 0001193125-09-260469 ↗ |
| 2010-02-16 | F-1/A | F-1/A (amendment) | Med BioGene Inc. | 0001193125-10-032459 ↗ |
| 2010-03-19 | F-1/A | F-1/A (amendment) | Med BioGene Inc. | 0001193125-10-061983 ↗ |
| 2010-04-13 | F-1/A | F-1/A (amendment) | Med BioGene Inc. | 0001193125-10-081739 ↗ |
| 2010-04-23 | F-1/A | F-1/A (amendment) | Med BioGene Inc. | 0001193125-10-091956 ↗ |
| 2010-05-07 | F-1/A | F-1/A (amendment) | Med BioGene Inc. | 0001193125-10-113114 ↗ |
| 2010-05-27 | F-1/A | F-1/A (amendment) | Med BioGene Inc. | 0001193125-10-130794 ↗ |
| 2010-06-09 | F-1/A | F-1/A (amendment) | Med BioGene Inc. | 0001193125-10-135551 ↗ |
| 2010-06-22 | F-1/A | F-1/A (amendment) | Med BioGene Inc. | 0001193125-10-143377 ↗ |
| 2012-02-02 | RW | RW (withdrawal request) | Med BioGene Inc. | 0001193125-12-036730 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2010-06-09 | F-1/A | registration statement | $8.00–$10.00 | $9.00 | 2,777,778 | $25,000,002 | Nasdaq MBGI | 3 | primary document; range, price sentence, shares headline, proceeds computed, cover names 3 | document ↗ |
| 2010-06-22 | F-1/A | registration statement | - | - | 0 | primary document; no terms found | document ↗ |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Others with the same interests
SIC industry Services-Medical Laboratories, A1 first:
- Centogene N.V. 2M
- DYNACARE INC A6
- GenEmbryomics Ltd C3
- MDxHealth SA C9
- INSIGHT HEALTH SERVICES CORP CA
- CLARIENT, INC CA
- BIOCEPT INC CA
- SPECIALTY LABORATORIES INC CA
- GENOMIC HEALTH INC CA
- PERLEGEN SCIENCES, INC. CA
In other datasets, the same topic (Health) in A1:
- Form D issuer: 1219014 B.C. Ltd. (Form D private offerings)
Interests: Services-Medical Laboratories · Health